BYLINE: New Drug Is Helping To Fight Alzheimer's

Claudia Padilla, MD, at Baylor Scott & White Health, discusses Alzheimer’s and a new treatment.

What You Need to Know:

  • Alzheimer’s disease is a type of dementia.
  • The most common sign is short-term memory loss.
  • New medication targets the protein that causes the disease.
  • New treatment slows the disease’s progression.

For interviews or health story ideas, visit Baylor Scott & White’s Health News For Journalists page.

MEDIA CONTACT
Register for reporter access to contact details
TYPE OF ARTICLE
Expert Pitch
SECTION
CHANNELS
Healthspan Alzheimer's and Dementia Neuro
KEYWORDS
Brain Alzheimer's Disease Alzheimer's Disease Alzheimer's Disease Alzheimer's Disease Alzheimer's & Dementia Dementia Alzheimer's Disease Alzheimer's Disease Alzheimer's Disease Alzheimer's Disease Dementia Dementia Dementia Alzheimer's Disease Memory Loss Memory Loss Causes memory loss problems Cognitive Decline Cognitive decline and aging lecanemab Amyloid Amyloid Protein Amyloid Proteins
COMMENTS | COMMENTING POLICY